BR9911183A - In-vivo determination of the effects of a pharmaceutical product on blood parameters - Google Patents

In-vivo determination of the effects of a pharmaceutical product on blood parameters

Info

Publication number
BR9911183A
BR9911183A BR9911183-7A BR9911183A BR9911183A BR 9911183 A BR9911183 A BR 9911183A BR 9911183 A BR9911183 A BR 9911183A BR 9911183 A BR9911183 A BR 9911183A
Authority
BR
Brazil
Prior art keywords
pharmaceutical product
living organism
effects
blood
blood parameters
Prior art date
Application number
BR9911183-7A
Other languages
Portuguese (pt)
Inventor
Kenneth Kensey
Original Assignee
Visco Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visco Technologies Inc filed Critical Visco Technologies Inc
Priority claimed from PCT/US1999/013943 external-priority patent/WO1999066839A1/en
Publication of BR9911183A publication Critical patent/BR9911183A/en

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

<B>''DETERMINAçãO IN-VIVO DOS EFEITOS DE UM PRODUTO FARMACêUTICO SOBRE OS PARâMETROS SANGUìNEOS''<D> - Métodos para a seleção de um produto farmacêutico a fim de determinar sua eficácia na alteração da viscosidade do sangue de um organismo vivo, compreendendo um instrumento in-vivo dispostos de forma a se acoplar ao sangue que flui dentro do sistema vascular de um organismo vivo; método compreendendo a etapa de introdução de um produto farmacêutico (ou outro composto) no corpo de um organismo vivo e utilização do instrumento in-vivo para determinar o provável efeito do produto farmacêutico introduzido sobre a viscosidade do sangue de um organismo vivo; método compreendendo a etapa de introdução de um produto farmacêutico (ou outro composto) no corpo de um organismo vivo e utilização do instrumento in-vivo para determinar o provável efeito do produto farmacêutico introduzido sobre a deformidade dos eritrócitos no sangue de um organismo vivo; método compreendendo a etapa de introdução de um produto farmacêutico (ou outro composto) no corpo de um organismo vivo e utilização do instrumento in-vivo para determinar o provável efeito do produto farmacêutico introduzido sobre as propriedades tixotrópicas de um organismo vivo.<B> '' IN-LIVE DETERMINATION OF THE EFFECTS OF A PHARMACEUTICAL PRODUCT ON BLOOD PARAMETERS '' <D> - Methods for the selection of a pharmaceutical product in order to determine its effectiveness in altering the blood viscosity of a living organism, comprising an in-vivo instrument arranged to couple with the blood flowing within the vascular system of a living organism; a method comprising the step of introducing a pharmaceutical product (or other compound) into the body of a living organism and using the in-vivo instrument to determine the likely effect of the introduced pharmaceutical product on the blood viscosity of a living organism; a method comprising the step of introducing a pharmaceutical product (or other compound) into the body of a living organism and using the in-vivo instrument to determine the likely effect of the introduced pharmaceutical product on the deformity of erythrocytes in the blood of a living organism; method comprising the step of introducing a pharmaceutical product (or other compound) into the body of a living organism and using the in-vivo instrument to determine the likely effect of the introduced pharmaceutical product on the thixotropic properties of a living organism.

BR9911183-7A 1999-06-22 1999-06-22 In-vivo determination of the effects of a pharmaceutical product on blood parameters BR9911183A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1999/013943 WO1999066839A1 (en) 1997-08-28 1999-06-22 In-vivo determining the effects of a pharmaceutical on blood parameters
US10323299A 1999-06-23 1999-06-23

Publications (1)

Publication Number Publication Date
BR9911183A true BR9911183A (en) 2001-02-13

Family

ID=22294085

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911183-7A BR9911183A (en) 1999-06-22 1999-06-22 In-vivo determination of the effects of a pharmaceutical product on blood parameters

Country Status (1)

Country Link
BR (1) BR9911183A (en)

Similar Documents

Publication Publication Date Title
NO20006467L (en) In-vivo determination of the effects of a pharmaceutical product on blood parameters
DK1298436T3 (en) Process for Identifying Inhibitor Compounds for the Release of Beta-Amyloid Peptide (BAP)
WO2003001966A3 (en) Diagnostic capsule and method of use
BR9611047A (en) Detection process of oxygenase-2 cycle
Jamali et al. Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: intestinal chiral inversion
BR0210579A (en) Antibodies, heavy and light chains, pharmaceutical composition and methods of detection of opgl level in biological sample and treatment
BR0113663A (en) Pectin Film Compositions
DE69932191D1 (en) Device for the examination of body fluid
CA2421007A1 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
FR2801778B1 (en) CONNECTION ASSEMBLY FOR THE FIELD OF RACHIDIAN OSTEOSYNTHESIS
BR9911861A (en) Farnesyl protein transferase inhibitors with radiosensitizing properties in vivo
BR9713921A (en) Compound, pharmaceutical composition, process for logician capable of being modulated through factor xa inhibition
BR0309256A (en) Temperature responsive release systems
PT931264E (en) DIAGNOSTIC METHOD OF ATEROSCLEROSIS
PT931265E (en) DIAGNOSTIC METHOD OF ATEROSCLEROSIS
BR9813514A (en) Agent for the treatment of keratin fibers
BR9911183A (en) In-vivo determination of the effects of a pharmaceutical product on blood parameters
BR9810205A (en) Use of intravenous contrast agents for projection mammography
BR0012661A (en) Treatment Methods and Drug Screening Methods
DE60037676D1 (en) METHOD FOR DIAGNOSIS OF RICKETTSIA PULICIS
SE0002287D0 (en) biotin
PT1097140E (en) IMIDAZOLE DERIVATIVES SUBSTITUTED WITH BIPHENYLSULPHONYL PROCESS FOR THE PREPARATION OF ITS APPLICATION AS A MEDICINE OR DIAGNOSTIC MEDIUM AND A MEDICINAL PRODUCT INCLUDED
BR0111726A (en) Biotin Derivatives
BR0213410A (en) Pharmaceutical uses of bisphosphonates
BR0009947A (en) Antimicrobial conjugate, method of eliminating viable microorganisms, medical device, and method of forming an antimicrobial conjugate

Legal Events

Date Code Title Description
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement
B25E Requested change of name of applicant rejected

Owner name: VISCO TECHNOLOGIES, INC (US)

Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME DO TITULAR REQUERIDO ATRAVES DA PETICAO 037183/RJ DE 11/07/2002, POR FALTA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI 1773 DE 28/12/2004.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1865 DE 03/10/2006.

B15K Others concerning applications: alteration of classification

Ipc: G01N 11/04 (2006.01), G01N 33/15 (2006.0